ResMed Inc (BSP:R1MD34)
R$ 368.7 0.14 (0.04%) Market Cap: 216.49 Bil Enterprise Value: 218.91 Bil PE Ratio: 32.69 PB Ratio: 6.97 GF Score: 87/100

Q2 2023 Resmed Inc Earnings Call Transcript

Jan 26, 2023 / 09:30PM GMT
Release Date Price: R$308.78
Operator

Hello, and welcome to the ResMed Second Quarter Fiscal Year 2023 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded.

It's now my pleasure to turn the call over to Amy Wakeham, Vice President, Investor Relations and Corporate Communications. Amy, please go ahead.

Amy Wakeham
ResMed Inc. - VP of IR & Corporate Communications

Great. Thank you, Kevin. Hi, everyone. Happy New Year, and welcome to ResMed's Second Quarter Fiscal Year 2023 Earnings Call. Thanks for joining us. This call is being webcast live and the replay will be available on the Investor Relations section of our corporate website later today, along with a copy of the earnings press release and the presentation, both of which are available now.

Joining me on the call today are Chief Executive Officer and Chairman, Mick Farrell; and Chief Financial Officer, Brett Sandercock. Mick will provide a brief high-level overview of our financial results, review our progress towards ResMed's 2025 strategic goals and discuss our progress as we continue

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot